2022
DOI: 10.3389/fphar.2022.982893
|View full text |Cite
|
Sign up to set email alerts
|

Plant polysaccharides with anti-lung injury effects as a potential therapeutic strategy for COVID-19

Abstract: When coronavirus disease 2019 (COVID-19) develops into the severe phase, lung injury, acute respiratory distress syndrome, and/or respiratory failure could develop within a few days. As a result of pulmonary tissue injury, pathomorphological changes usually present endothelial dysfunction, inflammatory cell infiltration of the lung interstitium, defective gas exchange, and wall leakage. Consequently, COVID-19 may progress to tremendous lung injury, ongoing lung failure, and death. Exploring the treatment drugs… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 150 publications
0
1
0
Order By: Relevance
“…Polysaccharides are considered to be the primary active ingredient of plants ( Huang et al, 2022 ; Li et al, 2022 ). Currently, polysaccharides of DF have been used as dietary supplements.…”
Section: Pharmacologymentioning
confidence: 99%
“…Polysaccharides are considered to be the primary active ingredient of plants ( Huang et al, 2022 ; Li et al, 2022 ). Currently, polysaccharides of DF have been used as dietary supplements.…”
Section: Pharmacologymentioning
confidence: 99%